Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound shows superior efficacy in glucose control and weight management compared to similar peptides.
Our pharmaceutical grade Tirzepatide compound offers 99.9% purity and comes in convenient 10mg vials. The white powder form ensures easy handling and precise dosing for research applications. Clinical studies indicate significant weight loss potential with this innovative peptide.
As a dual agonist, Tirzepatide demonstrates greater affinity for GIP receptors than GLP-1 receptors, producing enhanced hyperglycemia reduction. The molecular structure includes PEG modification for improved water solubility and bioavailability.
Research indicates average weight reduction of 15-20% in clinical trials when using Tirzepatide compound over 72 weeks. This makes it a promising candidate for obesity-related research applications.
For researchers looking to buy Tirzepatide compound in UK, we offer flexible quantities from small research batches to bulk pharmaceutical orders. All products are strictly for laboratory research use only.
